Meridian Clinical Research, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Meridian Clinical Research, LLC - overview

Established

1999

Location

Omaha, NE, US

Primary Industry

Pharmaceuticals

About

Based in Nebraska, US, and founded in 1999 by Nicole Osborn (CEO), Meridian Clinical Research, LLC operates as a pharmaceutical company that provides services such as the research of new drugs, medical devices, and diagnostics as well as high-volume vaccine trials. In December 2022, Velocity Clinical Research Inc. , a portfolio company of GHO Capital, acquired Meridian Clinical Research, LLC. Meridian Clinical Research, LLC is a clinical research services provider for pharmaceutical and biotechnology companies.


The company conducts phase 1-4 studies to support research in a range of medical specialties and specializes in increased vaccine trials, assisting clients in their search for new drugs, medical devices, and diagnostics that could improve human health and well-being. The acquisition held in December 2022 enables the company to allow Velocity Clinical Research Inc. to have sites in over 25 US states and employ 1500 clinical research employees.


Current Investors

Velocity Clinical Research Inc.

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.mcrmed.com

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Meridian Clinical Research, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedMeridian Clinical Research, LLC-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.